Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Congress Urged to Pass the Vaccine Injury Compensation Modernization Act as a Long-Overdue Path to Justice for COVID Vaccine Injury Victims


News provided by

mctlaw

Jul 19, 2026, 11:20 ET

Share this article

Share toX

Share this article

Share toX


The legal team at mctlaw urges Congress to pass the Vaccine Injury Compensation Modernization Act of 2026 (H.R. 9672), which would finally include COVID vaccine injury claims in the National Vaccine Injury Compensation Program. Attorney Altom Maglio, who advised on the bill's drafting, says the current system has failed injured Americans, denying more than 99 percent of decided claims. The legislation would add COVID vaccines to the Vaccine Injury Table, raise compensation caps, and extend the filing deadline to five years.

WASHINGTON, July 19, 2026 /PRNewswire-PRWeb/ -- The legal team at mctlaw is urging Congress to quickly pass the Vaccine Injury Compensation Modernization Act of 2026 (H.R. 9672), legislation that would include COVID vaccine injury claims in the National Vaccine Injury Compensation Program, or VICP, and update the program for the first time in decades.

mctlaw attorney Altom Maglio assisted with the bill's drafting along with React-19, a patient-led advocacy and research non-profit for the COVID-19 vaccine-injured. Maglio has represented vaccine injured clients in the VICP for more than two decades and since the introduction of the COVID vaccine has been working to bring COVID vaccine injuries under the VICP.

For more than five years, people hurt by the COVID vaccine have been told to wait, told to file paperwork that goes nowhere, and rejected by a program that was never built to handle something like the COVID vaccine. This legislation fixes that. Congress needs to act on it without delay.

Post this

"This bill is the single most important step Congress can take right now to help the people that our current system has failed," said Maglio. "For more than five years, people hurt by the COVID vaccine have been told to wait, told to file paperwork that goes nowhere, and rejected by a program that was never built to handle something like the COVID vaccine. This legislation fixes that. Congress needs to act on it without delay."

What the Vaccine Injury Compensation Modernization Act does for COVID vaccine injury victims

  • Requires HHS to add the COVID vaccine to the Vaccine Injury Table.
  • Raises the number of special masters who decide VICP cases from eight to at least ten.
  • Increase the compensation cap for death and for pain and suffering to $600,000.
  • Extends the deadline to file a claim from three years to five years.

"People keep asking why the vaccine we were told to take to protect others is the one vaccine not included in the system built to protect people that suffer severe adverse reactions," Maglio said. "There has never been a good answer to that question. This bill is Congress finally handling COVID vaccine injuries the right way."

Currently, COVID vaccine injury claims cannot be filed in the VICP. They can be filed in the Countermeasures Injury Compensation Program, or CICP. This is a program built for rare emergencies, not for a vaccine given to hundreds of millions of Americans.

HRSA data as of July 1, 2026 shows the failure of the CICP:

  • 14,146 COVID vaccine injury claims have been filed
  • 6,562 are still waiting for a decision, more than five years after the vaccine became widely available
  • Of the 7,584 claims actually decided, only 62 out of thousands have been compensated, less than point one percent
  • 99% percent of claims were denied compensation, almost always for vague administrative reasons, not a lack of merit.

The VICP has paid out more than $5.5 billion dollars to nearly 13,000 injured Americans. Claims are decided by the U.S. Court of Federal Claims in a judicial process. In contrast, claims filed in the CICP enter a black hole with no accountability, zero transparency over why claims are rejected, and no opportunity to appeal a decision made by an unknown official.

mctlaw has represented vaccine injury clients nationwide for more than 25 years and has led the legal effort to bring COVID vaccine injuries into the VICP, including a federal lawsuit alleging HHS missed its legal deadline to add the COVID vaccine to the Vaccine Injury Table.

"I have sat across the table from clients who lost their jobs, their savings, and their health because of an adverse vaccine reaction, and then watched the government deny them," Maglio said. "That is not how this system is supposed to work. Congress built the VICP because it understood that when we ask people to get vaccinated for the good of everyone, we owe anyone who gets hurt a fair and honest path to help. This bill restores that promise, and it restores it for COVID vaccine victims most of all."

The legal team at mctlaw urges lawmakers from both parties to move the bill forward without delay and encourages anyone who has experienced a severe reaction to a vaccine, particularly a COVID vaccine, to contact their representatives in support of this legislation.

About mctlaw, a national vaccine injury compensation law firm

mctlaw is a national law firm representing people harmed by vaccines, defective medical products, and government overreach. The firm has represented clients in the U.S. Court of Federal Claims through the Vaccine Injury Compensation Program for nearly 25 years and has offices in Washington, D.C., Seattle, Washington, and Sarasota, Florida.

Media Contact

Altom Maglio, mctlaw, 1 (941) 879-9913, [email protected], www.mctlaw.com

SOURCE mctlaw

Modal title

Copy of Bill H.R. 9672 - The Vaccine Injury Compensation Modernization Act of 2026
View PDF
Copy of Bill H.R. 9672 - The Vaccine Injury Compensation Modernization Act of 2026
Copy of Bill H.R. 9672 - The Vaccine Injury Compensation Modernization Act of 2026

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.